Rapport Therapeutics (NASDAQ:RAPP) Shares Gap Up – Here’s What Happened

Rapport Therapeutics (NASDAQ:RAPP)’s share price gapped up before the market opened on Wednesday . The stock had previously closed at $12.69, but opened at $13.51. Rapport Therapeutics shares last traded at $13.76, with a volume of 11,234 shares.

Rapport Therapeutics Stock Performance

The stock’s 50 day moving average price is $20.00 and its 200 day moving average price is $21.36.

Institutional Investors Weigh In On Rapport Therapeutics

Institutional investors and hedge funds have recently modified their holdings of the company. Charles Schwab Investment Management Inc. bought a new stake in shares of Rapport Therapeutics in the 3rd quarter valued at about $1,498,000. Millennium Management LLC bought a new stake in shares of Rapport Therapeutics in the 2nd quarter valued at about $2,716,000. Perceptive Advisors LLC bought a new stake in shares of Rapport Therapeutics in the 2nd quarter valued at about $17,403,000. ARCH Venture Management LLC bought a new stake in shares of Rapport Therapeutics in the 2nd quarter valued at about $86,730,000. Finally, Geode Capital Management LLC bought a new stake in shares of Rapport Therapeutics in the 3rd quarter valued at about $4,133,000.

About Rapport Therapeutics

Rapport Therapeutics Inc is a clinical-stage biotechnology company. It focused on discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. Rapport Therapeutics Inc is based in BOSTON.